Daryl Geers
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccination.
Journal: The Journal of infection
Published: November 20, 2025
Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 05, 2024
SARS-CoV-2-specific B cell responses in non-draining lymph nodes and antibody functionalities in immunized end-stage renal disease patients.
Journal: Scientific reports
Published: November 27, 2024
The effect of sleep and shift work on the primary immune response to messenger RNA-based COVID-19 vaccination.
Journal: Journal of sleep research
Published: July 11, 2024
Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled Trial.
Journal: Transplantation
Published: June 21, 2024
Profiling the SARS-CoV-2-specific T-cell response.
Journal: The Lancet. Infectious diseases
Published: May 31, 2024
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.
Journal: AIDS (London, England)
Published: May 24, 2024
Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants.
Journal: The Journal of infection
Published: May 15, 2024
Rational attenuation of canine distemper virus (CDV) to develop a morbillivirus animal model that mimics measles in humans.
Journal: Journal of virology
Published: February 28, 2024
Polysaccharide, Conjugate, and mRNA-based Vaccines are Immunogenic in Patients with Netherton Syndrome.
Journal: Journal of clinical immunology
Published: November 23, 2023
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.
Journal: Nature communications
Published: September 26, 2023
Last Updated: 09/26/2026